DCSIMG

Doncaster man first to trial new wonder drug

Peter Wynne pictured with Nicola Lancaster, Senior Research Sister of the South Yorkshire Comprehensive Local Research Network (SYCLRN).

Peter Wynne pictured with Nicola Lancaster, Senior Research Sister of the South Yorkshire Comprehensive Local Research Network (SYCLRN).

A Doncaster man suffering from severe arthritis is benefitting from the trial of a new drug at Doncaster and Bassetlaw Hospitals.

Peter Wynne, aged 63, of Chalmers Drive, who suffers severe rheumatoid arthritis in his hands, knees and shoulders, agreed to take part in the ‘Ascertain Trial’ after he was contacted by Consultant Rheumatologist Dr Chee-Seng Yee.

He was the first person in Europe to sign up for the trial and as part of it has been receiving fortnightly injections of the drug Surilumab.

Mr Wynne said: “I have suffered with arthritis for the last 23 years and over the last few years it’s got gradually worse.

“I was asked to take part in the trial and I spoke to my wife about it and we agreed that I had nothing to lose.”

Since starting the treatment he said his hands are not as painful or inflamed, adding: “They used to be very stiff in a morning – it could take half an hour to get them loose.

“There is no cure for arthritis, you’ve just got to find a way to manage.”

Dr Yee added: “It’s great that Mr Wynne’s arthritis is responding well and hopefully that will continue for him. When I came to Doncaster and Bassetlaw Hospitals I wanted to bring in more clinical trials like this.”

The trial will end in April.

Mr Wynne said: “I’m the first in Europe to be on this drug and if it’s a success hopefully it will become available, as it is not yet licensed to the NHS.”

 

Comments

 
 

Back to the top of the page